help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piatti, P. M.
Right arrow Articles by Pozza, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piatti, P. M.
Right arrow Articles by Pozza, G.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 34-40, Copyright © 1995 by Endocrine Society


ARTICLES

The continuous low dose insulin and glucose infusion test: a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies

PM Piatti, LD Monti, A Caumo, G Santambrogio, F Magni, M Galli-Kienle, S Costa, AE Pontiroli, KG Alberti and G Pozza
Istituto Scientifico San Raffaele, Cattedra di Clinica Medica, Universita di Milano, Italy.

In this study we investigated a simple nonlabor-intensive method to evaluate insulin sensitivity and beta-cell function which is suitable for application in population studies. The method is a refinement of the modified Harano test and consists of a continuous low dose insulin (25 mU/kg.h) and glucose (4 mg/kg.min) infusion test (LDIGIT) lasting 150 min. Insulin sensitivity was evaluated as the MCR of glucose divided by the steady state serum insulin level achieved at the end of the test. Insulin secretion was expressed as the incremental area for C- peptide concentration during the first 15 min of the test. We compared the indices of insulin sensitivity and insulin secretion yielded by LDIGIT with those derived from the euglycemic clamp and the hyperglycemic clamp, respectively. Fifty-four subjects underwent a LDIGIT (33 with normal glucose tolerance and 21 with impaired glucose tolerance); of the 54, 19 were submitted to a euglycemic clamp, 18 to a hyperglycemic clamp, and 10 to a modified Harano test (insulin infusion, 50 mU/kg.h; glucose infusion, 6 mg/kg.min). LDIGIT overcame the drawbacks associated with the modified Harano test because it resulted in more stable final glucose levels and prevented the occurrence of hypoglycemic episodes. No significant differences were found between the insulin sensitivity index (ISI) of the LDIGIT and that of the euglycemic clamp for each group of subjects. Moreover, there was a strong correlation between the ISI determined by LDIGIT and the ISI determined by clamp (r = 0.90; P < 0.0001), and the best regression line was not different from the identity line, suggesting that the two indices are equivalent. The index of insulin secretion provided by LDIGIT correlated well with that of the hyperglycemic clamp (r = 0.82; P < 0.001) and was significantly higher in overweight subjects than in normal weight subjects. In conclusion, LDIGIT is a simple and accurate method to assess insulin sensitivity and secretion. It can be useful in population studies and in situations when more complex techniques are not feasible.


This article has been cited by other articles:


Home page
DiabetesHome page
H. Chen, G. Sullivan, and M. J. Quon
Assessing the Predictive Accuracy of QUICKI as a Surrogate Index for Insulin Sensitivity Using a Calibration Model
Diabetes, July 1, 2005; 54(7): 1914 - 1925.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. R. Zilkens, V. Burke, G. Watts, L. J. Beilin, and I. B. Puddey
The Effect of Alcohol Intake on Insulin Sensitivity in Men: A randomized controlled trial
Diabetes Care, March 1, 2003; 26(3): 608 - 612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin
Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension
Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Parker, M. Noakes, N. Luscombe, and P. Clifton
Effect of a High-Protein, High-Monounsaturated Fat Weight Loss Diet on Glycemic Control and Lipid Levels in Type 2 Diabetes
Diabetes Care, March 1, 2002; 25(3): 425 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. M. PIATTI, L. D. MONTI, I. ZAVARONI, G. VALSECCHI, C. VAN PHAN, S. COSTA, M. CONTI, E. P. SANDOLI, B. SOLERTE, G. POZZA, et al.
Alterations in Nitric Oxide/Cyclic-GMP Pathway in Nondiabetic Siblings of Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2416 - 2420.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Hovorka, L. Chassin, S. D. Luzio, R. Playle, and D. R. Owens
Pancreatic {beta}-Cell Responsiveness during Meal Tolerance Test: Model Assessment in Normal Subjects and Subjects with Newly Diagnosed Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 744 - 750.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society